NCT03060434View on ClinicalTrials.gov

Pentoxifylline and Lumbar Radiculopathy

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2026

Conditions
Lumbar RadiculopathyLumbar Disc HerniationLumbar Disc Disease
Interventions
DRUG

Pentoxifylline Oral Tablet

patient will receive for 15 days: Ibuprofen 600 mg bid; pregabalin 75 mg bid; paracetamol 1 g tid; pentoxifylline 400 mg bid

DRUG

Ibuprofen

patient will receive for 15 days: Ibuprofen 600 mg bid; pregabalin 75 mg bid; paracetamol 1 g tid

Trial Locations (1)

16 6830

Hotel Dieu de France Hospital, Beirut

All Listed Sponsors
lead

St Joseph University, Beirut, Lebanon

OTHER

NCT03060434 - Pentoxifylline and Lumbar Radiculopathy | Biotech Hunter | Biotech Hunter